AARTIPHARM.BOAARTIPHARM.BOBSE
Loading
EBITDA Margin Over TimeStrong
Percentile Rank100
3Y CAGR+10.6%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
+10.6%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1.4x
Solid growth
Streak
4 yr
Consecutive growthStrong
PeriodValueYoY Change
202522.43%+4.2%
202421.53%+21.6%
202317.70%+6.7%
202216.60%-
20210.00%-
20200.00%-